Jeffrey Hrkach
Technik-/Wissenschafts-/F&E-Leiter bei Nvelop Therapeutics, Inc.
Profil
Jeffrey Hrkach is currently an Advisor at Atlas Venture Advisors, Inc. and the Chief Technology Officer at Nvelop Therapeutics, Inc. He previously worked as the Director-Pulmonary Formulations at Alkermes, Inc., Senior Director-Drug Delivery at Momenta Pharmaceuticals, Inc., Manager at Sandoz, Inc., Principal at Novartis AG, and Senior Vice President-Technology Development at Frequency Therapeutics, Inc. He also served as the Chief Technology Officer at DNIB Unwind, Inc. from 2007 to 2014.
Dr. Hrkach holds a doctorate degree from Carnegie Mellon University and an undergraduate degree from Philadelphia College of Pharmacy.
Aktive Positionen von Jeffrey Hrkach
Unternehmen | Position | Beginn |
---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Berater | 01.03.2022 |
Nvelop Therapeutics, Inc.
Nvelop Therapeutics, Inc. Personnel ServicesCommercial Services Nvelop Therapeutics, Inc. provides staffing services. The American company was founded by David Liu, J. Keith Joung. The CEO is Thomas J. Cahill. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Ehemalige bekannte Positionen von Jeffrey Hrkach
Unternehmen | Position | Ende |
---|---|---|
DNIB UNWIND INC | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2014 |
KORRO BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Hrkach
Carnegie Mellon University | Doctorate Degree |
Philadelphia College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVARTIS AG | Health Technology |
Private Unternehmen | 7 |
---|---|
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Nvelop Therapeutics, Inc.
Nvelop Therapeutics, Inc. Personnel ServicesCommercial Services Nvelop Therapeutics, Inc. provides staffing services. The American company was founded by David Liu, J. Keith Joung. The CEO is Thomas J. Cahill. | Commercial Services |